C
Caliway Biopharmaceuticals Co., Ltd
Profile managed by Bizz Id
Taiwan
1-10 employees
2012
Description
Taiwanese biopharmaceutical company founded in 2012 and listed on Taiwan SE (6919). Develops new drugs for aesthetic medicine and chronic inflammatory diseases. Lead product CBL-514 is an injectable for subcutaneous fat reduction, with Phase IIb results validated and Phase 3 ongoing.